Flumatinib in CML-CP Patients With Ph+ Post Imatinib Failure

NCT04677439 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Flumatinib
Chronic Myeloid Leukemia, Chronic Phase
Imatinib

Interventions

DRUG: Flumatinib

Sponsor

Shenzhen Second People's Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]